SRX Health Solutions Inc. Common Stock (SRXH)

FairStock Score: 15/100 — RISKY

Key Financials

Concerns

• High leverage at 5.97x debt-to-equity increases financial risk and interest expense burden
• Altman Z-Score of -0.7 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

SRX Health Solutions Inc. Common Stock is a micro-cap consumer defensive company valued at $57 million. Revenue stands at $9 million. From a quality standpoint, SRX shows distressed Altman Z-Score of -0.7 warrants caution and highly leveraged at 5.97x D/E. Growth dynamics show profit growth of -116.3%. Our composite FairStock Score of 15/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Elevated leverage at 6.0x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer